374Water Inc. (SCWO): Nasdaq/NYSE listing notice — 374Water fails Nasdaq independent director rule; cure period until March 9, 2026

374Water Inc.

Company notified Nasdaq on March 13, 2025 it lacks a majority of independent directors per Listing Rule 5605(b)(1).
Cure period expires at earlier of next annual meeting or March 9, 2026; if meeting before Sept 8, 2025, then by Sept 8, 2025.
Company plans to elect an additional independent director as soon as practicable to regain compliance.
No immediate impact on listing or trading of SCWO common stock on Nasdaq Capital Market.
2025 Annual Meeting scheduled for June 11, 2025; stockholder proposals due by April 12, 2025.

item 3.01 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

374Water Inc. received a nasdaq deficiency notice notice regarding board independence (rules 5605(b)(1), 5605(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: board independence
Rules: 5605(b)(1), 5605(a)(2)

Exact text from the filing

March 13, 2025, 374Water Inc. (the “Company”) notified the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company no longer complies with Nasdaq’s independent director requirement as set forth in Nasdaq Listing Rule 5605(b)(1), which requires a majority of the Company’s Board of Directors (the “Board”) to be comprised of Independent Directors as defined in Nasdaq Listing Rule 5605(a)(2). On that same date, the Company received a letter from Nasdaq confirming the foregoing (the “Letter”). Consistent with Nasdaq Listing Rule 5605(b)(1)(A

View on SEC.gov

Browse all listing & compliance notices →

374Water Inc. filing history →

Source: SEC EDGAR

accession 0001654954-25-003032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.